跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FRAGMIN dalteparin sodium 12,500 anti-Xa IU/0.5mL injection syringe - TGA Drug Approval Details
Approvals
/
TGA
/
FRAGMIN dalteparin sodium 12,500 anti-Xa IU/0.5mL injection syringe
Approved
STANDARD
FRAGMIN dalteparin sodium 12,500 anti-Xa IU/0.5mL injection syringe
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
e0a05c3506cf468c
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e0a05c3506cf468c
Product Name
FRAGMIN dalteparin sodium 12,500 anti-Xa IU/0.5mL injection syringe
Artg Id
61939
Artg Name
FRAGMIN dalteparin sodium 12,500 anti-Xa IU/0.5mL injection syringe
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1997-11-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8b4b190d516d987b810c0e4763bedb33.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6ce347540e7250f93d4b652425487615.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
e0a05c3506cf468c
Type
Standard
Back to TGA Approvals